ISRCTN86579667已完成未知
Efficacy of EPs 7630 in children with acute non-streptococcal tonsillopharyngitis
ISO Arzneimittel GmbH & Co KG (Germany)0 个研究点目标入组 78 人开始时间: 2003年3月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 78
研究概览
简要总结
Results article in https://pubmed.ncbi.nlm.nih.gov/14526713/ (added 07/10/2021)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients who met the following inclusion criteria were suitable for the trial:
- •1. Age 6¿10 years, acute tonsillopharyngitis, duration of complaints less than 48 h, negative dip-and-react-test test for ß-hemolytic streptococcus and severity of symptoms =6 points
- •2. In addition legal guardians had to sign an informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitisISRCTN03930168ISO Arzneimittel GmbH & Co KG (Germany)60
已完成
不适用
Efficacy of EPs 7630 compared to placebo in children with acute non-streptococcal tonsillopharyngitisAcute tonsillopharyngitisRespiratoryTonsillopharyngitisISRCTN27398531ISO Arzneimittel GmbH & Co KG (Germany)124
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderJPRN-jRCT2080222070SHIONOGI & CO., LTD.
未知
2 期
Phase II/III Study of S-877503 in Pediatric Patients with Attention-deficit/Hyperactivity Disorder -Long term Extension StudyAttention-deficit/Hyperactivity DisorderJPRN-jRCT2080222071SHIONOGI & CO., LTD.
未知
1 期
A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitisatopic dermatitisJPRN-jRCT2080222693Eisai Co., Ltd.24